Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal (U01 Research Project (Cooperative Agreement) Clinical Trial not allowed)
ID: RFA-DK-26-313 • Type: Posted
Opportunity Assistant
Loading
Overview
Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 2/6/26 the National Institutes of Health posted grant opportunity RFA-DK-26-313 for Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal (U01 Research Project (Cooperative Agreement) Clinical Trial not allowed).
The grant will be issued under grant program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
It is expected that one grant will be made.
Timing
Posted Date
Feb. 6, 2026, 12:00 a.m. EST
Closing Date
March 10, 2026, 12:00 a.m. EDT Past Due
Last Updated
Feb. 6, 2026, 10:39 a.m. EST
Version
1
Archive Date
May 5, 2026
Eligibility
Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Only the following applicant is eligible to apply for this single source funding: The Broad Institute, Inc. Please refer to Section I. Notice of Funding Opportunity Information for more details.
Award Sizing
Ceiling
$2,000,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
1
Contacts
Contact
National Institutes of Health
Contact Email
niddk_dem@nih.gov   Profile
Contact Phone
(301) 402-2541
Documents
Posted documents for RFA-DK-26-313
Opportunity Assistant
AI Analysis
AI Generate